As of 2026-09-21, the EV/EBITDA ratio of Clearpoint Neuro Inc (CLPT) is -17.49. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. CLPT's latest enterprise value is 428.81 mil USD. CLPT's TTM EBITDA according to its financial statements is -24.52 mil USD. Dividing these 2 quantities gives us the above CLPT EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 14.4x - 16.2x | 15.0x |
| Forward P/E multiples | 17.7x - 20.6x | 18.8x |
| Fair Price | (14.97) - (13.73) | (14.25) |
| Upside | -208.3% - -199.3% | -203.0% |
| Date | EV/EBITDA |
| 2026-09-17 | -17.38 |
| 2026-09-16 | -16.96 |
| 2026-09-15 | -16.65 |
| 2026-09-14 | -17.03 |
| 2026-09-11 | -17.35 |
| 2026-09-10 | -17.06 |
| 2026-09-09 | -17.55 |
| 2026-09-08 | -17.76 |
| 2026-09-04 | -17.65 |
| 2026-09-03 | -17.76 |
| 2026-09-02 | -18.07 |
| 2026-09-01 | -18.79 |
| 2026-08-31 | -19.09 |
| 2026-08-28 | -19.59 |
| 2026-08-27 | -20.07 |
| 2026-08-26 | -20.59 |
| 2026-08-25 | -21.31 |
| 2026-08-24 | -19.12 |
| 2026-08-21 | -19.39 |
| 2026-08-20 | -19.15 |
| 2026-08-19 | -20.09 |
| 2026-08-18 | -19.14 |
| 2026-08-17 | -19.53 |
| 2026-08-14 | -19.33 |
| 2026-08-13 | -19.43 |
| 2026-08-12 | -19.14 |
| 2026-08-11 | -18.79 |
| 2026-08-10 | -18.39 |
| 2026-08-07 | -17.95 |
| 2026-08-06 | -16.95 |
| 2026-08-05 | -16.67 |
| 2026-08-04 | -16.32 |
| 2026-08-03 | -19.38 |
| 2026-07-31 | -18.84 |
| 2026-07-30 | -18.40 |
| 2026-07-29 | -17.87 |
| 2026-07-28 | -18.34 |
| 2026-07-27 | -18.43 |
| 2026-07-24 | -17.84 |
| 2026-07-23 | -18.29 |
| 2026-07-22 | -18.95 |
| 2026-07-21 | -19.42 |
| 2026-07-20 | -18.98 |
| 2026-07-17 | -19.10 |
| 2026-07-16 | -18.99 |
| 2026-07-15 | -19.74 |
| 2026-07-14 | -20.09 |
| 2026-07-13 | -20.76 |
| 2026-07-10 | -21.97 |
| 2026-07-09 | -22.44 |